脑性瘫痪儿童共病尿失禁的研究进展

doi:10.11852/zgetbjzz2023-1075

摘要/Abstract

摘要： 脑性瘫痪(CP)是一种慢性、非进行性的脑损伤,其特征是由于产前发育异常或围生期或产后中枢神经系统损伤而导致的自主运动障碍。尿失禁是CP儿童常见的泌尿系统问题之一,对康复进程和生活质量有负面影响。本综述主要关注CP儿童尿失禁的流行病学、评估诊断、危险因素和治疗措施的研究进展,从而减少危险因素的影响和进行早期干预,提高CP儿童达到排尿自制的可能性。

关键词: 脑性瘫痪, 尿失禁, 自主运动障碍

Abstract: Cerebral palsy (CP) is a chronic, non-progressive brain injury characterized by autonomic dyskinesia due to prenatal developmental abnormalities or perinatal or postpartum central nervous system damage.Urinary incontinence is one of the common urinary problems in children with CP, which has a negative impact on the recovery process and quality of life.This review summarizes the epidemiology, assessment, diagnosis, risk factors and treatment of urinary incontinence in children with CP, so as to provide reference for reducing the influence of risk factors and taking early intervention to improve the possibility of urinary self-control in children with CP.

Key words: cerebral palsy, urinary incontinence, autonomic dyskinesia

中图分类号:

R742.3

刘家豪, 郭津, 公超, 方立雅, 连贝贝, 李佳蔚, 刘媛媛. 脑性瘫痪儿童共病尿失禁的研究进展[J]. 中国儿童保健杂志, 2024, 32(7): 772-777.

LIU Jiahao, GUO Jin, GONG Chao, FANG Liya, LIAN Beibei, LI Jiawei, LIU Yuanyuan. Research progress of comorbidity urinary incontinence in children with cerebral palsy[J]. Chinese Journal of Child Health Care, 2024, 32(7): 772-777.

参考文献

[1] 唐久来, 秦炯, 邹丽萍, 等. 中国脑性瘫痪康复指南(2015):第一部分[J]. 中国康复医学杂志, 2015, 30(7): 747-754.
Tang JL, Qing J, Zou LP, et al. Chinese guidelines for rehabilitation of cerebral palsy(2015): Part Ⅰ[J]. Chin J Rehabil Med, 2015, 30(7): 747-754.(in Chinese)
[2] 李晓捷, 唐久来, 马丙祥. 中国脑性瘫痪康复指南(2022)第一章:概论[J]. 中华实用儿科临床杂志, 2022, 37(12): 887-892.
Li XJ, Tang JL, Ma BX. Chinese guidelines for rehabilitation of cerebral palsy(2022): Part Ⅰ[J]. Chin J Appl Clin Pediatr, 2022, 37(12): 887-892.(in Chinese)
[3] 李晓捷,邱洪斌, 姜志梅, 等. 中国十二省市小儿脑性瘫痪流行病学特征[J]. 中华实用儿科临床杂志, 2018, 33(5): 378-383.
Li XJ, Qiu HB, Jiang ZM, et al. Epidemiological characteristics of cerebral palsy in children in 12 provinces of China[J]. Chin J Appl Clin Pediatr, 2018, 33(5): 378-383.(in Chinese)
[4] Wu H. Achieving urinary continence in children[J]. NatRev Urol, 2010, 7(7): 371-377.
[5] Neveus T, Fonseca E, Franco I, et, al. Management and treatment of nocturnal enuresis-an updated standardization document from the International Children's Continence Society[J]. J Pediatr Urol, 2020, 16(1): 10-19.
[6] Veriki M, Coomer A, Simmonds JV. Parental perceptions of bladder dysfunction in children with symptomatic joint hypermobility[J]. Am J Med Genet C Semin Med Genet, 2021, 187(4): 586-592.
[7] Buckley BS, Sanders CD, Spineli L, et al. Conservative interventions for treating functional daytime urinary incontinence in children[J].Cochrane Database Syst Rev, 2019, 9: CD12367.
[8] Buckley BS,Sanders CD, Kwong JSW, et al. Conservative treatment for functional daytime urinary[J]. Cochrane Database Syst Rev, 2016, (9): 1-11.
[9] Unal B, Pisirici P, Kurt AK, et al. Comparison of the efficiency of transcutaneous electrical nerve stimulation and manual therapy in children with cerebral palsy with lower urinary system dysfunction- a randomized prospective trial[J]. J Pediatr Urol, 2024, 30(1): e1-e8.
[10] Playfair M, Elliott S, Welk B.The assessment and management of voiding dysfunction in adults living with cerebral palsy[J]. World J Urol. 2023, 41(11): 3317-3323.
[11] Yildiz N, Akkoc Y, Ersoz M, et al. Cross-sectional study of urinary problems in adults with cerebral palsy: Awareness and impact on the quality of life[J]. Neurol Sci. 2017, 38(7): 1193-1203.
[12] Wright AJ, Fletcher O, Scrutton D, et al. Bladder and bowel continence in bilateral cerebral palsy: A population study[J]. J Pediatr Urol, 2016, 12(6): 383.e1-383.e8.
[13] Schaeffer AJ, Diamond AD. Pediatric urinary incontinence: Classification, evaluation, and management[J]. Afric J Urol, 2014(20): 1-13.
[14] Roijen LEG, Postema K, Limbeek VJ, et al. Development of bladder control in children and adolescents with cerebral palsy[J]. Dev Med Child Neurol, 2001, 43(2): 103-107.
[15] Murphy N, Such-Neibar T. Cerebral palsy diagnosis and management:The state of the art[J]. Curr Probl Pediatr Adolesc Health Care, 2003, 33(5): 146-169.
[16] Wang MH, Harvey J, Baskin L. Management of neurogenic bladder in patients with cerebral palsy[J]. J Pediatr Rehabil Med, 2008, 1(2): 123-125.
[17] Samijn B, Laecke EV, Renson C, et al. Lower urinary tract symptoms and urodynamic findings in children and adults with cerebral palsy: A systematic review[J]. Neurourol Urodyn, 2017, 36(3): 541-549.
[18] Buckon CE, Koscielniak NJ, Tucker CA, et, al. Mode of anesthesia and bladder management following orthopaedic surgery in children with cerebral palsy: A system level analysis[J]. J Pediatr Orthop, 2022, 42(5): e544-e549.
[19] Lee CL, Lee G, Park JM. Sophisticated regulation of micturition: Review of basic neurourology[J]. J Exerc Rehabil, 2021, 17(5): 295-301.
[20] Ryakitimbo A, Philemon R, Mazuguni F, et al. Prevalence and antimicrobial sensitivity pattern of urinary tract infection among children with cerebral palsy, Moshi, Tanzania[J]. Pediatric Health Med Ther, 2018, 9: 59-65.
[21] Gontard AV, Jong TPVMD, Badawi JK, et al. Psychological and physical environmental factors in the development of incontinence in adults and children: A comprehensive review[J]. J Wound Ostomy Continence Nurs, 2017, 44(2): 181-187.
[22] Wang XS, Ying XQ, Zhang F, et al. Upper urinary dilatation and treatment of 26 patients with diabetes insipidus: A single-center retrospective study[J]. Front Endocrinol (Lausanne), 2022, 13: 659-664.
[23] Talu B. Determine therelationship between abdominal muscle strength, trunk control and urinary incontinence in children with diplegic cerebral palsy[J]. Urol J, 2018, 15(4): 180-185.
[24] Marciniak C, O′Shea SA, Lee J, et al. Urinary incontinence in adults with cerebral palsy: prevalence, type, and effects on participation[J]. PM&R, 2014, 6(2): 110-120.
[25] Murphy KP, Boutin SA, Ide KR. Cerebral palsy, neurogenic bladder, and outcomes of lifetime care[J]. Dev Med Child Neurol, 2012, 54(10): 945-950.
[26] Richardson I, Palmer LS. Clinical and urodynamic spectrum of bladder function in cerebral palsy[J]. J Urol, 2009, 182(4): 1945-1948.
[27] Tekgul S, Stein R, Bogaert G, et al. EAU-ESPU guidelines recommendations for daytime lower urinary tract conditions in children[J]. Eur J Pediatr, 2020, 179(7): 1069-1077.
[28] Peyronnet B, Mironska E, Chapple C, et al. A comprehensive review of overactive bladder pathophysiology: On the way to tailored treatment[J]. Eur Urol, 2019, 75(6): 988-1000.
[29] Jiang WB, Sun HZ, Gu BJ, et al. Urodynamic study findings and related influential factors in pediatric spastic cerebral palsy[J]. Sci Rep, 2022, 12(1): 6962.
[30] Baram M, Zuk L, Stattler T, et al. Theprevalence of bladder and bowel dysfunction in children with cerebral palsy and its association with motor, cognitive, and autonomic function[J]. Dev Neurorehabil, 2023, 26(3): 155-162.
[31] Turker A, Ozkeskin M. Investigation of urinary disorders, functional independence, and quality of life in children with cerebral palsy[J]. Neurourol Urodyn, 2023, 42(3): 597-606.
[32] Monbaliu E, Cock PD, Ortibus E, et al. Clinical patterns of dystonia and choreoathetosis in participants with dyskinetic cerebral palsy[J]. Dev Med Child Neurol, 2016, 58(2): 138-144.
[33] Narayan VM, Pariser JJ, Gor RA, et al. Bladder changes after catheterizable channel creation in adults with cerebral palsy who are in chronic urinary retention[J]. Neurourol Urodyn, 2019, 38(1): 165-170.
[34] Ryakitimbo A, Philemon R, Mazuguni F, et al. Prevalence and antimicrobial sensitivity pattern of urinary tract infection among children with cerebral palsy, Moshi, Tanzania[J]. Pediatric Health Med Ther, 2018, 9: 59-65.
[35] Cornwell LB, Ewing E, Algra J, et al. Acute urinary retention in pediatric cerebral palsy: Is there an optimal management strategy?[J]. J Pediatr Urol, 2021, 17(4): 527.e1-527.e7.
[36] Bottet F, Peyronnet B, Boissier R, et al. Switch to abobotulinum toxin a may be useful in the treatment of neurogenic detrusor overactivity when intradetrusor injections of onabotulinum toxin A failed[J]. Neurourol Urodyn, 2018, 37(1): 291-297.
[37] Chang SJ, Van Laecke E, Bauer SB, et al. Treatment of daytime urinary incontinence: A standardization document from the International Children's Continence Society[J]. Neurourol Urodyn, 2017, 36(1): 43-50.
[38] Samijn B, Van den Broeck C, Plasschaert F, et al. Incontinence training in children with cerebral palsy: A prospective controlled trial[J]. J Pediatr Urol, 2022, 18(4): 441-447.
[39] Gontard AV. Elimination disorders -ICD- 11 classification and definitions[J]. Z Kinder Jugendpsychiatr Psychother, 2021, 49(6): 421-428.
[40] Paulson A, Vargus-Adams J. Overview of four functional classification systems commonly used in cerebral palsy[J]. Children(Basel), 2017, 4(4): 30.
[41] Sommer-Joergensen V, Sarcevic J, Haecker FM, et al. Dysfunctional Voiding and Incontinence Scoring System for children and adolescents: A tool to predict clinical course and outcome[J]. Eur J Pediatr Surg, 2022, 32(5): 429-434.
[42] Ginsberg DA, Boone TB, Cameron AP, et al. The AUA/SUFU guideline on adult neurogenic lower urinary tract dysfunction: Diagnosis and evaluation[J]. J Urol, 2021, 206(5): 1097-1105.
[43] Borch L, Hagstroem S, Kamperis K, et al. Combing transcutaneous electrical nerve stimulation combined(TENS) with oxybutynin is superior to monotherapy in children with urge incontinence: A randomized, placebo controlled study[J]. J Urol, 2017, 198(2): 430-435.
[44] DeWitt-Foy ME, Gotlieb R, Elliott SP. Long-term follow-up of patients with cerebral palsy undergoing catheterizable channel creation without concurrent bladder augmentation[J]. Urology, 2022, 170: 234-239.
[45] 崔占武, 赵建中. 膀胱过度活动症治疗药物临床研究进展[J]. 中国临床药理学杂志, 2021, 37(4): 473-478.
Cui ZW, Zhao JZ. Clinical research progress on therapeutic drugs for overactive bladder[J].Chin J Clin Pharmacol, 2021, 37(4): 473-478.(in Chinese)
[46] 刘书航. 膀胱过度活动症的临床特点及药物治疗进展[J]. 医学理论与实践, 2018,31(5): 653-657.
Liu SH. Clinical characteristics and drug treatment progress of overactive bladder[J]. J Med Theor &Prac, 2018, 31(5): 653-657.(in Chinese)
[47] 张晔,潮敏. 奥昔布宁联合去氨加压素治疗儿童夜间遗尿症的临床研究[J]. 中国临床药理学杂志,2022,38(20):2415-2418.
Zhang Y, Chao M. Study on the efficacy of oxybutynin combined with desmopressin in the treatment of nocturnal enuresis in children[J]. Chin J Clin Pharmacol,2022, 38(20):2415-2418.(in Chinese)
[48] Vande Velde S, Van Renterghem K, Van Winkel M, et al. Constipation and fecal incontinence in children with cerebral palsy. Overview of literature and flowchart for a stepwise approach[J]. Acta Gastroenterol Belg, 2018, 81(3): 415-418.
[49] Zhan QJ, Yu XY, Jiang WB, et al. Whether the newly modified rhizotomy protocol is applicable to guide single-level approach SDR to treat spastic quadriplegia and diplegia in pediatric patients with cerebral palsy?[J]. Childs Nerv Syst, 2020, 36(9): 1935-1943.
[50] Assis GM, Silva CPCD, Martins G. Urotherapy in the treatment of children and adolescents with bladder and bowel dysfunction: A systematic review[J]. J Pediatr (Rio J), 2019, 95: 628-641.
[51] Cui HQ, Yao Y, Xu ZN, et al. Role of transcutaneous electrical nerve stimulation in treating children with overactive bladder from pooled analysis of 8 randomized controlled trials[J]. Int Neurourol J, 2020, 24(1): 84-94.
[52] Nieuwhof-Leppink AJ, Hussong J, Chase J, et al. Definitions, indications and practice of urotherapy in children and adolescents: A standardization document of the International Children's Continence Society (ICCS)[J]. J Pediatr Urol, 2021, 17(2): 172-181.